...
首页> 外文期刊>Neuropsychopharmacology >Synapse-Associated Protein 90|[sol]|Postsynaptic Density-95-Associated Protein (SAPAP) is Expressed Differentially in Phencyclidine-Treated Rats and is Increased in the Nucleus Accumbens of Patients with Schizophrenia
【24h】

Synapse-Associated Protein 90|[sol]|Postsynaptic Density-95-Associated Protein (SAPAP) is Expressed Differentially in Phencyclidine-Treated Rats and is Increased in the Nucleus Accumbens of Patients with Schizophrenia

机译:突触相关蛋白90 | [sol] |突触后密度95相关蛋白(SAPAP)在苯环利定治疗的大鼠中差异表达,并在精神分裂症患者的伏隔核中增加。

获取原文
           

摘要

Phencyclidine (PCP) induces a psychotomimetic state that closely resembles schizophrenia. Therefore, PCP-treated animals can provide a model for schizophrenia. Using differential display, we identified a gene regulated by the delayed action of PCP in rat nucleus accumbens (NAcs). Sequence analysis showed that the cDNA clone obtained was identical to rat synapse-associated protein 90/postsynaptic density-95-associated protein 1 (SAPAP1). Quantitative reverse transcriptase (RT)-PCR analysis showed that SAPAP1 mRNA had increased significantly in rat NAc (PPPN-methyl-D-aspartate (NMDA) receptors.
机译:苯环利定(PCP)诱导拟精神分裂症状态,类似于精神分裂症。因此,用五氯苯酚治疗的动物可以为精神分裂症提供模型。使用差异显示,我们确定了由大鼠伏伏核(NAcs)中PCP的延迟作用调节的基因。序列分析表明,获得的cDNA克隆与大鼠突触相关蛋白90 /突触后密度95相关蛋白1(SAPAP1)相同。定量逆转录酶(RT)-PCR分析表明,SAPAP1 mRNA在大鼠NAc(PPPN-甲基-D-天冬氨酸(NMDA)受体)中显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号